From October 1, 2023 to October 4, 2023, the company has repurchased 75,109 shares, representing 0.09% for $0.17 million. With this, the company has completed the repurchase of 3,132,012 shares, representing 3.96% for $5.98 million under the buyback announced on November 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | -4.87% | -7.33% | -2.71% |
05-20 | Standard BioTools Receives Shareholder Proposal from Madryn Asset Management | CI |
05-08 | Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.71% | 795M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on November 28, 2022.